CCCaio Hernandes Colhado

Caio Hernandes Colhado

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Caio Hernandes Colhado has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis of randomized controlled trials at 12 months

    by Nathan Joseph Silva Godinho, Juan Carlos de Miranda Onofre, Caio Hernandes Colhado, Marcos Antonio Dias Vilela, Thales Henrique Figueiredo Menezes, Marco Antonio Andrade, Henrique Gomes Rodrigues, Lucas G. C. R. de Amorim, Rodrigo Donalisio da Silva

    Purpose This network meta-analysis evaluates efficacy outcomes of established and emerging techniques to inform evidence-based clinical decision-making. Materials and methods PubMed, EMBASE, and Cochrane Library were searched for randomized controlled trials comparing minimally invasive treatments for benign prostatic hyperplasia. Primary outcomes encompassed urinary function, sexual function, safety, and durability. Network meta-analysis was conducted using MetaInsight. Results Among 36 randomized controlled trials and 4851 patients, no individual intervention significantly outperformed bTURP in either symptom control, peak urinary flow, hospital stay, complications, or medical retreatment at 12 months. PUL was the only technique significantly inferior to bTURP in bladder emptying (PVR: MD 67.47 mL; 95% CrI 11.02–125.79), yet demonstrated superior ejaculatory function preservation over mTURP/bTURP (MSHQ-EjD: MD 4.99; 95% CrI 1.32–8.64) without differences in ejaculatory bother. HoLEP showed significantly lower surgical retreatment rates versus bTURP and mTURP, and HoLEP and ThuLEP demonstrated shorter catheterization times versus bTURP (MD −36.26 h and −26.89 h, respectively). When grouped by category, stent/implant devices were significantly inferior to enucleation, ablation, and resection in urinary outcomes, yet demonstrated superior ejaculatory function preservation versus resection (MSHQ-EjD: MD 5.01; 95% CrI 1.33–8.65) without differences in ejaculatory bother. Enucleation was the only category with significantly reduced surgical retreatment versus sham. Conclusions No intervention surpassed bTURP in urinary efficacy. HoLEP demonstrated superior durability, while stent/implant approaches and PUL showed inferior urinary outcomes. Preservation of ejaculatory function with stent/implant techniques did not translate into reduced patient-reported bother.

  • Open Access

    A comparison of prostate cancer detection rates between TRUS-GB and MRI-GB: a systematic review and meta-analysis

    by Nathan Joseph S. Godinho, Caio H. Colhado, Marcos A. D. Vilela, Marco Antônio A. Junior, Lucas G. C. R. Amorim, Thales Henrique F. Menezes, Guilherme C. R. Silva, Ricardo G. Alvim

    Background: Prostate cancer (PCa) is one of the most common cancers in men and a major cause of cancer-related death. Accurate diagnosis is essential to identify clinically significant cases while avoiding overdiagnosis. Traditionally, prostate biopsies are performed as systematic sampling using transrectal ultrasound guidance (systematic TRUS-GB), whereas lesion-targeted multiparametric magnetic resonance imaging–guided biopsy (lesion-targeted mpMRI-GB) has emerged as a promising alternative. While lesion-targeted mpMRI-GB may improve cancer detection, its clinical advantage over systematic TRUS-GB remains debated. This meta-analysis compares the detection rates of PCa between lesion-targeted mpMRI-GB and systematic TRUS-GB in biopsy-naive patients. Main body: We systematically searched PubMed, Cochrane Central, Scielo, and LILACS for studies comparing lesion-targeted mpMRI-GB to systematic TRUS-GB in biopsy-naive patients suspected of having PCa. Outcomes included the detection rate of overall PCa, clinically significant PCa, clinically insignificant PCa, and missed diagnoses. We included 9,165 patients from 14 studies, of which three were randomized controlled trials (RCTs). lesion-targeted mpMRI-GB was used to diagnose overall PCa in 4,349 (47,45%) patients. The cancer detection rate of overall PCa (RR 1.26; 95% CI 1.02–1.55; p < 0.00001; i² = 95%) and clinically significant PCa (RR 1.46; 95% CI 1.11–1.93; p = 0.007; i² = 93%) were significantly higher in patients diagnosed with lesion-targeted mpMRI-GB. The detection rate of clinically insignificant cancer (RR 0.85; CI 0.64–1.13; p = 0.25; I² = 77%) was not statistically significant. However, missed diagnoses were lower in the systematic TRUS-GB group, showing a potential difference. Subgroup analysis was evaluated. Conclusions: Using lesion-targeted mpMRI-GB as a first-line approach increases the likelihood of detecting clinically significant prostate cancer. However, lesion-targeted mpMRI-GB has not demonstrated clear superiority over systematic TRUS-GB in reducing missed diagnoses, suggesting that the choice of technique should be individualized or that a combined biopsy strategy may be considered.

  • Single-session bilateral vs. staged unilateral renal stone removal: comparative outcomes in a systematic review and meta-analysis

    by Marco Antonio Andrade, Nathan Joseph Silva Godinho, Lucas Guimarães. C. R. de Amorim, Matheus Pinhati, Caio Hernandes Colhado, Daniel DaJusta

    There is still controversy regarding the best approach to bilateral renal urolithiasis. Single-session bilateral (SSB) renal stone removal is considered superior due to fewer procedures and less anesthesia exposure. However, doubts persist about its effectiveness and safety compared to staged unilateral (SU) procedures, particularly concerning complications and stone-free rates (SFR). We conducted a systematic review and meta-analysis to compare outcomes of these approaches. We hypothesize that SSB procedures have similar outcomes in terms of complications and SFR with fewer interventions. A meta-analysis following Cochrane and PRISMA guidelines included studies from 2002 to 2024 comparing SSB to SU procedures. Searches were conducted in PubMed, Cochrane, and EMBASE, focusing on complication rates, SFR, operative time, and additional procedures. The search yielded 13 studies with a total of 836,414 patients, of which 7,854 were in the SSB group. The rate of severe complications (Clavien-Dindo grade ≥ 3) was not significantly different between SSB versus SU groups (RR 1.22; 95% CI 0.65-2.26; P = 0.53). Nevertheless, overall complication rates were notably higher for SSB procedures (RR 1.32; 95% CI 1.08-1.62; P = 0.007). SFR was similar between approaches (RR 0.89; 95% CI 0.74-1.07; P = 0.23). Importantly, SSB procedures resulted in significantly longer operative times (MD 27.93 minutes; 95% CI 7.78-48.07; P = 0.007) and had a significantly higher need for unplanned additional interventions (RR 1.65; 95% CI 1.44-1.89; P < 0.00001).The search yielded 13 studies with a total of 836,414 patients, of which 7,854 were in the SSB group. The rate of severe complications (Clavien-Dindo grade ≥ 3) was not significantly different between SSB versus SU groups (RR 1.22; 95% CI 0.65-2.26; P = 0.53). Nevertheless, overall complication rates were notably higher for SSB procedures (RR 1.32; 95% CI 1.08-1.62; P = 0.007). SFR was similar between approaches (RR 0.89; 95% CI 0.74-1.07; P = 0.23). Importantly, SSB procedures resulted in significantly longer operative times (MD 27.93 minutes; 95% CI 7.78-48.07; P = 0.007) and had a significantly higher need for unplanned additional interventions (RR 1.65; 95% CI 1.44-1.89; P < 0.00001). SSB procedures achieve similar SFR and severe complication rates as SU procedures but involve longer operative times and higher overall complication rates. Their advantage lies in reducing planned surgical sessions, offering fewer anesthesia exposures, though this benefit is offset by an increased need for unplanned additional procedures.